Pro-HIFU System - Pro300 - Hepatocellular Carcinoma and Liver Metastasis

Non-invasive High-Intensity Focused Ultrasound Therapy

Treatment Solution

The Pro-HIFU Pro300 System is a non-invasive therapeutic platform that utilizes High-Intensity Focused Ultrasound (HIFU) to ablate targeted pathological tissue without surgical incision. By concentrating ultrasound energy at a precise focal point, the system induces thermal coagulative necrosis while preserving surrounding healthy structures.

Pro-HIFU offers an effective, uterus-preserving and organ-preserving treatment option for selected benign and malignant conditions, providing patients with faster recovery, reduced complications, and improved quality of life.

Disease Overview

What is Hepatocellular Carcinoma and Liver Metastasis?

Liver tumours can occur either as primary liver cancer, most commonly hepatocellular carcinoma (HCC), or as liver metastases, where cancer has spread to the liver from another part of the body. Whether primary or secondary, these tumours can have a significant impact on liver function, overall health, and the direction of cancer care. In some patients, they remain silent in the early stages, while in others they may cause abdominal discomfort, fatigue, reduced appetite, weight loss, or abnormal liver function. Because the liver is both a vital and sensitive organ, management must be carefully individualised, taking into account the nature of the tumour, the condition of the surrounding liver tissue, and the patient’s broader clinical picture. In selected cases, a focused, non-invasive approach to local tumour control may play an important role in supporting effective treatment while helping to preserve healthy liver tissue.

Clinical Applications

How Pro-HIFU Treats Hepatocellular Carcinoma and Liver Metastasis

Pro-HIFU enables precise, non-invasive ablation of liver tumors by focusing ultrasound energy under image guidance, minimizing damage to surrounding liver tissue.

Key Benefits